Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
108studies shown
Showing 76-100 of 108
WithdrawnNCT00470639

Transcranial Magnetic Stimulation for Depression in bipolarity

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

DepressionOtherFrom 18 Years to 80 Years
Countries
Australia
Sponsor
The University of New South Wales
Condition
Depression
CompletedNCT03266679

Psychological Factors In The Treatment Of Bipolar Mood Disorders

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

BipolarityOther
Countries
Australia
Sponsor
Queensland University of Technology
Condition
Bipolarity
CompletedNCT00483548

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

DepressionOtherOver 18 Years
Countries
Australia, India, United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Depression
CompletedNCT00436020

rTMS in the Treatment of Depression in bipolarity

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 18 Years to 70 Years
Countries
Australia
Sponsor
Bayside Health
Condition
Depression
TerminatedNCT01121536

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolarity I

This study exists to better understand the safety of a therapy or guided support program and how manageable it feels in practice. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

DepressionOtherFrom 18 Years to 65 Years
Countries
Argentina, Australia, Brazil, Bulgaria, Canada, Croatia, France, Germany, Hungary, Italy, Poland, Serbia, Slovakia, South Africa, Spain, Ukraine, United States
Sponsor
Cephalon
Condition
Depression
CompletedNCT00202293

Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can work better when mental health difficulties overlap with substance use.

SchizophreniaOtherFrom 15 Years to 29 Years
Countries
Australia
Sponsor
Melbourne Health
Condition
Schizophrenia
CompletedNCT01890356

Maintenance Transcranial Electrical Stimulation for Depression

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.

DepressionOtherOver 18 Years
Countries
Australia
Sponsor
The University of New South Wales
Condition
Depression
CompletedNCT02118623

Internet-Based Interventions for Bipolarity (MoodSwings 2)

This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can make support easier to access outside standard clinic visits.

BipolarityOtherFrom 21 Years to 65 Years
Countries
Australia
Sponsor
University of Melbourne
Condition
Bipolarity
CompletedNCT01358357

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

This study exists to understand how the medication Lurasidone holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication Lurasidone in practice and what may need to be adjusted.

BipolarityOtherOver 18 Years
Countries
Argentina, Australia, Bulgaria, Chile, Croatia, Czech Republic, France, Hungary, Japan, Poland, Russian Federation, Serbia, Slovakia, United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity
CompletedNCT01072630

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolarity I

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

DepressionOtherFrom 18 Years to 65 Years
Countries
Argentina, Australia, Bulgaria, Canada, France, Poland, South Africa, Spain, Ukraine, United States
Sponsor
Cephalon
Condition
Depression
CompletedNCT01562184

Investigating tDCS as a Treatment for Unipolar and Depression in bipolarity

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

DepressionOtherOver 18 Years
Countries
Australia, United States
Sponsor
The University of New South Wales
Condition
Depression
CompletedNCT01339598

Remediation of Cognitive Dysfunction in Euthymic Bipolarity Patients Using Transcranial Direct Current Stimulation (tDCS)

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Australia
Sponsor
The University of New South Wales
Condition
Bipolarity
CompletedNCT01076361

Model 4968 CAPTURE EPI® STERIOD-ELUTING BIPOLAR EPICARDIAL PACING LEAD Post-approval Study

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

BipolarityOther
Countries
Australia, Austria, Belgium, Canada, Denmark, France, Germany, Italy, Netherlands, Serbia and Montenegro, Spain, Sweden, Switzerland, United States
Sponsor
Medtronic
Condition
Bipolarity
CompletedNCT05402657

The RAFT ECT Study

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

DepressionOtherOver 18 Years
Countries
Australia, United States
Sponsor
The George Institute
Condition
Depression
CompletedNCT06003309

Frequency and E-field Enhancement of ITBS for Depression (FREED)

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 18 Years to 80 Years
Countries
Australia, United States
Sponsor
University of California, San Diego
Condition
Depression
RecruitingNCT07315516

Sleep and Stress Study

This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve sleep, daily rhythms, and longer-term stability.

AnxietyOtherOver 18 Years
Countries
Australia
Sponsor
RDC Clinical Pty Ltd
Condition
Anxiety
Active Not RecruitingNCT05528302

Technology Assisted Cognitive Behavioural Therapy Intervention for Anxiety in People Living With Cognitive Impairment

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

AnxietyOtherOver 18 Years
Countries
Australia
Sponsor
The University of Queensland
Condition
Anxiety
CompletedNCT06593847

Multisite Virtual Reality Intervention for Speech Anxiety

This study exists to understand what helps a therapy or guided support program work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

AnxietyOtherFrom 18 Years to 70 Years
Countries
Australia, China, Germany, Netherlands, United States
Sponsor
Boston University Charles River Campus
Condition
Anxiety
RecruitingNCT06483789

Efficacy and Safety of HB-1 for Panic Disorder

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

AnxietyOtherFrom 18 Years to 65 Years
Countries
Australia
Sponsor
HB BioTech, LLC
Condition
Anxiety
RecruitingNCT06947941

A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

This study exists to explore whether this type of care could improve care and understanding. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

SchizophreniaOtherFrom 55 Years to 90 Years
Countries
Australia, Canada, Japan, United Kingdom, United States
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
TerminatedNCT05211947

A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 51 Years
Countries
Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Italy, Japan, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, Philippines, Poland, Portugal, Romania, Serbia, Slovakia, South Korea, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, United States
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
CompletedNCT04846868

Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)

This study exists to learn from real-world information that can show how the medication Iclepertin fits into care. Researchers are trying to understand whether the medication Iclepertin can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Australia, Brazil, Canada, China, Colombia, Germany, Greece, Italy, Japan, Mexico, New Zealand, Norway, Philippines, Poland, Sweden, Turkey, United States
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
CompletedNCT02751632

The Staged Treatment in Early Psychosis Study

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 12 Years to 25 Years
Countries
Australia
Sponsor
Orygen
Condition
Schizophrenia